Novozymes A/S (CPH:NSIS.B)
Denmark · Delayed Price · Currency is DKK 350.60
+8.60 (2.51%)
At close: Mar 20, 2026
Novozymes Market Cap
Novozymes has a market cap or net worth of 163.35 billion as of March 20, 2026. Its market cap has decreased by -19.22% in one year.
Market Cap
163.35B
Enterprise Value
183.74B
Revenue
31.05B
Ranking
n/a
PE Ratio
37.56
Stock Price
350.60
Market Cap Chart
Since February 26, 2001, Novozymes's market cap has increased from 14.15B to 163.35B, an increase of 1,054.56%. That is a compound annual growth rate of 10.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 163.35B | -13.98% |
| Dec 30, 2025 | 189.89B | 0.24% |
| Dec 30, 2024 | 189.43B | 84.24% |
| Dec 29, 2023 | 102.82B | 5.66% |
| Dec 30, 2022 | 97.30B | -34.61% |
| Dec 30, 2021 | 148.80B | 51.92% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DSV A/S | 366.65B |
| Danske Bank | 253.64B |
| A.P. Møller - Mærsk | 246.85B |
| Ørsted | 182.31B |
| Vestas Wind Systems | 153.92B |
| Carlsberg | 107.09B |
| Genmab | 100.50B |
| Coloplast | 96.10B |